Report Detail

Other Global Drug Discovery Technologies Market Size, Status and Forecast 2019-2025

  • RnM2734281
  • |
  • 16 July, 2019
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Other

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. This report studies the Drug Discovery Technologies market.
Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.
In 2018, the global Drug Discovery Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Drug Discovery Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Discovery Technologies development in United States, Europe and China.

The key players covered in this study
Agilent Technologies, Inc
Abbott Laboratories, Inc.
GE Healthcare Ltd.
Albany Molecular Research Inc.
Affymetrix Inc.
Arqule Inc.
Luminex Corporation
Bayer Healthcare AG
Novartis AG
Astrazeneca plc

Market segment by Type, the product can be split into
Biochips
High Throughput Screening
Pharmacogenomics
Genomics
Bioanalytical Instruments
Bioinformatics
Nanotechnology
Others (RNAi, combinatorial chemistry)

Market segment by Application, split into
Biopharmaceutical Companies
Pharmaceutical Companies
Research Institutes
Biotech Companies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Drug Discovery Technologies status, future forecast, growth opportunity, key market and key players.
To present the Drug Discovery Technologies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Drug Discovery Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Drug Discovery Technologies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biochips
      • 1.4.3 High Throughput Screening
      • 1.4.4 Pharmacogenomics
      • 1.4.5 Genomics
      • 1.4.6 Bioanalytical Instruments
      • 1.4.7 Bioinformatics
      • 1.4.8 Nanotechnology
      • 1.4.9 Others (RNAi, combinatorial chemistry)
    • 1.5 Market by Application
      • 1.5.1 Global Drug Discovery Technologies Market Share by Application (2014-2025)
      • 1.5.2 Biopharmaceutical Companies
      • 1.5.3 Pharmaceutical Companies
      • 1.5.4 Research Institutes
      • 1.5.5 Biotech Companies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Drug Discovery Technologies Market Size
    • 2.2 Drug Discovery Technologies Growth Trends by Regions
      • 2.2.1 Drug Discovery Technologies Market Size by Regions (2014-2025)
      • 2.2.2 Drug Discovery Technologies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Drug Discovery Technologies Market Size by Manufacturers
      • 3.1.1 Global Drug Discovery Technologies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Drug Discovery Technologies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Drug Discovery Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drug Discovery Technologies Key Players Head office and Area Served
    • 3.3 Key Players Drug Discovery Technologies Product/Solution/Service
    • 3.4 Date of Enter into Drug Discovery Technologies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Drug Discovery Technologies Market Size by Type (2014-2019)
    • 4.2 Global Drug Discovery Technologies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Drug Discovery Technologies Market Size (2014-2019)
    • 5.2 Drug Discovery Technologies Key Players in United States
    • 5.3 United States Drug Discovery Technologies Market Size by Type
    • 5.4 United States Drug Discovery Technologies Market Size by Application

    6 Europe

    • 6.1 Europe Drug Discovery Technologies Market Size (2014-2019)
    • 6.2 Drug Discovery Technologies Key Players in Europe
    • 6.3 Europe Drug Discovery Technologies Market Size by Type
    • 6.4 Europe Drug Discovery Technologies Market Size by Application

    7 China

    • 7.1 China Drug Discovery Technologies Market Size (2014-2019)
    • 7.2 Drug Discovery Technologies Key Players in China
    • 7.3 China Drug Discovery Technologies Market Size by Type
    • 7.4 China Drug Discovery Technologies Market Size by Application

    8 Japan

    • 8.1 Japan Drug Discovery Technologies Market Size (2014-2019)
    • 8.2 Drug Discovery Technologies Key Players in Japan
    • 8.3 Japan Drug Discovery Technologies Market Size by Type
    • 8.4 Japan Drug Discovery Technologies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Drug Discovery Technologies Market Size (2014-2019)
    • 9.2 Drug Discovery Technologies Key Players in Southeast Asia
    • 9.3 Southeast Asia Drug Discovery Technologies Market Size by Type
    • 9.4 Southeast Asia Drug Discovery Technologies Market Size by Application

    10 India

    • 10.1 India Drug Discovery Technologies Market Size (2014-2019)
    • 10.2 Drug Discovery Technologies Key Players in India
    • 10.3 India Drug Discovery Technologies Market Size by Type
    • 10.4 India Drug Discovery Technologies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Drug Discovery Technologies Market Size (2014-2019)
    • 11.2 Drug Discovery Technologies Key Players in Central & South America
    • 11.3 Central & South America Drug Discovery Technologies Market Size by Type
    • 11.4 Central & South America Drug Discovery Technologies Market Size by Application

    12 International Players Profiles

    • 12.1 Agilent Technologies, Inc
      • 12.1.1 Agilent Technologies, Inc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Drug Discovery Technologies Introduction
      • 12.1.4 Agilent Technologies, Inc Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.1.5 Agilent Technologies, Inc Recent Development
    • 12.2 Abbott Laboratories, Inc.
      • 12.2.1 Abbott Laboratories, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Drug Discovery Technologies Introduction
      • 12.2.4 Abbott Laboratories, Inc. Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.2.5 Abbott Laboratories, Inc. Recent Development
    • 12.3 GE Healthcare Ltd.
      • 12.3.1 GE Healthcare Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Drug Discovery Technologies Introduction
      • 12.3.4 GE Healthcare Ltd. Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.3.5 GE Healthcare Ltd. Recent Development
    • 12.4 Albany Molecular Research Inc.
      • 12.4.1 Albany Molecular Research Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Drug Discovery Technologies Introduction
      • 12.4.4 Albany Molecular Research Inc. Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.4.5 Albany Molecular Research Inc. Recent Development
    • 12.5 Affymetrix Inc.
      • 12.5.1 Affymetrix Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Drug Discovery Technologies Introduction
      • 12.5.4 Affymetrix Inc. Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.5.5 Affymetrix Inc. Recent Development
    • 12.6 Arqule Inc.
      • 12.6.1 Arqule Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Drug Discovery Technologies Introduction
      • 12.6.4 Arqule Inc. Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.6.5 Arqule Inc. Recent Development
    • 12.7 Luminex Corporation
      • 12.7.1 Luminex Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Drug Discovery Technologies Introduction
      • 12.7.4 Luminex Corporation Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.7.5 Luminex Corporation Recent Development
    • 12.8 Bayer Healthcare AG
      • 12.8.1 Bayer Healthcare AG Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Drug Discovery Technologies Introduction
      • 12.8.4 Bayer Healthcare AG Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.8.5 Bayer Healthcare AG Recent Development
    • 12.9 Novartis AG
      • 12.9.1 Novartis AG Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Drug Discovery Technologies Introduction
      • 12.9.4 Novartis AG Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.9.5 Novartis AG Recent Development
    • 12.10 Astrazeneca plc
      • 12.10.1 Astrazeneca plc Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Drug Discovery Technologies Introduction
      • 12.10.4 Astrazeneca plc Revenue in Drug Discovery Technologies Business (2014-2019)
      • 12.10.5 Astrazeneca plc Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Drug Discovery Technologies . Industry analysis & Market Report on Drug Discovery Technologies is a syndicated market report, published as Global Drug Discovery Technologies Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Drug Discovery Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,116.10
      4,674.15
      6,232.20
      3,638.70
      5,458.05
      7,277.40
      606,645.00
      909,967.50
      1,213,290.00
      324,987.00
      487,480.50
      649,974.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report